Raifarm is the leading professional service provider for pharmaceutical and biotechnological companies on high-growth emerging markets of Russia, the CIS, Eastern Europe, and China. The company started in early 2007; we are headquartered in Moscow (Russia) and have satellite offices in New York (the US), Kiev (Ukraine), Astana (Kazakhstan), Almaty (Kazakhstan), and (Shanghai) China. In three years we successfully completed in excess of 250 different projects (including 53 drug registrations) for more than 50 clients.

Our services include:

• ● Drug registration
• ● Market analysis
• ● Market access
• ● Marketing
• ● Sales and distribution
• ● In-licensing
• ● Industry consulting

Emerging markets are often characterized by large patient populations, and strong unmet demand for modern pharmaceutical products; they offer excellent commercialization opportunities and high growth rates for pharmaceutical manufacturers. While foreign companies often have the products and the desire to satisfy this need, they lack the local market know-how and ability to effectively enter new geographies. Raifarm’s mission is to connect these companies with patients who need their products. We dramatically improve market access for international companies and, as a result, help to advance healthcare in territories where we operate.

There are two key traits that are at the core of Raifarm and that define who we are: quality and ethics. In everything we do, we strive for the utmost in professionalism, integrity and quality. We are deeply committed to the success of our clients; and all our work, whether regulatory, marketing or any other, is done according to best available practices and is fully compliant with both Western and local standards, laws, and regulations.